Several damage biomarkers such as neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), and interleukin-18 (IL-18) have been studied in AKI, however these biomarkers tended to be specific with some clinical setting and gave some limitations. This evidence concerns the gene IL18 and acute kidney injury.